
Fern.ai is a life sciences-focused AI/ML platform designed to enhance the entire Med Tech lifecycle, empowering clients to manage compliance requirements and navigate the regulatory landscape efficiently. The platform offers solutions for product documentation, literature reviews, and regulatory submissions, leveraging RQM+'s 40 years of regulatory expertise. Fern.ai stands out with its Smart Authoring module and systematic literature review capabilities, which streamline processes and ensure accuracy. The company aims to reduce regulatory risk and support clients throughout their product lifecycle, making it a valuable partner for Med Tech companies and regulatory bodies.

Fern.ai is a life sciences-focused AI/ML platform designed to enhance the entire Med Tech lifecycle, empowering clients to manage compliance requirements and navigate the regulatory landscape efficiently. The platform offers solutions for product documentation, literature reviews, and regulatory submissions, leveraging RQM+'s 40 years of regulatory expertise. Fern.ai stands out with its Smart Authoring module and systematic literature review capabilities, which streamline processes and ensure accuracy. The company aims to reduce regulatory risk and support clients throughout their product lifecycle, making it a valuable partner for Med Tech companies and regulatory bodies.
Focus: AI platform for clinical evidence review and regulatory/compliance workflows in MedTech
Headquarters: Monroeville, Pennsylvania, United States
Founded: 2023
Funding: Seed round announced Mar 18, 2024
Known investor: SFC Capital
Clinical evidence review, regulatory compliance, and documentation workflows for medical technology products.
2023
Life sciences / MedTech / Healthtech
190000.00
“SFC Capital participation in Seed round”